Acrivon Therapeutics, Inc. · NASDAQ:ACRV
Levy Adam D. sold 1,142 Acrivon Therapeutics, Inc. shares (Form 4)
Traded Aug 4, 2026 · Filed Aug 6, 2026
On Aug 4, 2026, Levy Adam D. (Chief Financial Officer) sold 1,142 Acrivon Therapeutics, Inc. shares at US$1.57 for US$1,793, leaving 66,008 shares. Filed Aug 6, 2026 (Form 4).
- Sold
- 1,142 shares
- Price
- US$1.57
- Value
- US$1,793
- Holding after
- 66,008 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | Common Stock | Sale | 1,142 | US$1.57 | 66,008 | Direct |
Source
Related
- Acrivon Therapeutics, Inc.
- Levy Adam D.
- Acrivon Therapeutics, Inc. shareholders
- Form 4 · Levy Adam D. · May 20, 2026
- Form 4 · Miller Mary · Oct 7, 2026
- Form 4 · Levin Michaela · Sep 2, 2026
- Form 4 · Blume-Jensen Peter · Aug 27, 2026
- Form 4 · Peterson Katharine · Aug 20, 2026
- Form 4 · Miller Mary · Aug 20, 2026